Clinical study of acupuncture and moxibustion cycle sequential therapy for dysmenorrhea of adenomyosis of cold coagulation and blood stasis type

Phase 1

• Conditions: Adenomyosis

• Registration Number: ITMCTR2000004065
• Lead Sponsor: Third Affiliated Hospital of Zhejiang Chinese Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

(1) According to the diagnostic criteria of traditional Chinese and Western medicine, the auxiliary examination was mainly based on the results of transvaginal ultrasound;
(2) Aged 25 to 50 years old;
(3) Secondary dysmenorrhea, progressive aggravation, course of disease >=1 year;
(4) In the acute stage of dysmenorrhea, the visual analogue scale (VAS) of abdominal pain was more than 40 points;
(5) Did not receive any treatment for adenomyosis for at least 1 month;
(6) The subjects were informed and voluntarily signed informed consent.
The above 6 items can be included only if they meet the requirements at the same time.

Exclusion Criteria

(1) Patients with acute pelvic inflammation, uterine fibroids, adenomyoma or pelvic malignant tumor;
(2) Those who could not accept transvaginal ultrasound examination;
(3) Amenorrhea or menstruation over 60 days at the time of participating in the study;
(4) A history of adenomyosis or endometriosis related surgery;
(5) Those who are in the process of artificial cycle regulation;
(6) Pregnant and lactating women;
(7) The patients were complicated with serious life-threatening primary diseases such as cardio cerebrovascular system, liver, kidney and hematopoietic system, as well as psychiatric patients;
(8) There are any contraindications of acupuncture and moxibustion, wound or infection on the moxibustion site, or systemic diseases that the researchers think are not suitable for taking measures due to the moxibustion site;
(9) Participants in other subjects.
Any one of the above is excluded.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analogue score;

Secondary Outcome Measures

Name	Time	Method
The Endometriosis Health Profile-5;pictorial blood loss assessment chart;Cox dysmenorrhea symptom scale;